Tivicay for HIV-1 infection
Quick answer: Tivicay is used for HIV-1 infection as part of a integrase strand transfer inhibitor (insti) treatment regimen. Dolutegravir: inhibits HIV integrase preventing integration of viral DNA into host genome The specific dosing for HIV-1 infection is determined by your prescriber based on individual factors.
Why is Tivicay used for HIV-1 infection?
Tivicay belongs to the Integrase strand transfer inhibitor (INSTI) class. Dolutegravir: inhibits HIV integrase preventing integration of viral DNA into host genome This action makes it useful for treating or managing HIV-1 infection in patients for whom this approach is clinically appropriate.
It is one of several treatment options. Whether Tivicay is the right choice for a specific patient depends on the type and severity of HIV-1 infection, response to previous treatments, individual risk factors, and clinical guidelines.
Typical dosing for HIV-1 infection
Common adult dosing range: 50 mg once or twice daily depending on resistance/co-medication. The actual dose for HIV-1 infection depends on:
- Severity of the condition
- Patient's age, weight, and organ function
- Other medications being taken
- Treatment response and tolerability
For complete dosing details, see the Tivicay medicine page.
What to expect
Tivicay treatment for HIV-1 infection typically involves:
- Onset of effect: varies by indication and dose — some effects are immediate, others take days to weeks
- Treatment duration: some courses are short-term, others are long-term or lifelong depending on HIV-1 infection
- Monitoring: follow-up visits to assess response and adjust dosing
- Side-effect awareness: learning what to expect and what warrants medical attention
Alternatives to consider
If Tivicay is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Integrase strand transfer inhibitor (INSTI) for related options.
When to talk to your doctor
Discuss with your prescriber if you experience:
- Inadequate symptom control on Tivicay
- Side effects affecting daily life
- New medications or supplements that may interact
- Pregnancy planning or pregnancy
- Major changes in health status
Related information
Tivicay full prescribing information · All Integrase strand transfer inhibitor (INSTI) alternatives
Frequently asked questions
How effective is Tivicay for HIV-1 infection?
Effectiveness varies by individual response, dose, and severity. Tivicay is one of several treatment options for HIV-1 infection, supported by clinical evidence within the integrase strand transfer inhibitor (insti) class. Discuss expected response with your prescriber.
How long do I need to take Tivicay for HIV-1 infection?
Treatment duration depends on the nature of HIV-1 infection — some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.
What are the main side effects of Tivicay when used for HIV-1 infection?
Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.
Are there alternatives to Tivicay for HIV-1 infection?
Yes. Multiple medicines and non-drug options exist for HIV-1 infection. Alternatives within the integrase strand transfer inhibitor (insti) class share mechanisms; other classes may offer different approaches. Discuss with your clinician.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.